Downgrade Announcement#
Raymond James has downgraded Universal Health Services (NYSE: UHS) from an 'Outperform' rating to 'Market Perform.' This change was announced on Tuesday, and the stock has since dropped to $162.54, marking a nearly 10% decline over the past week. Currently, it is just 7% above its 52-week low of $152.33.
Concerns Over Earnings Guidance#
The downgrade stems from concerns regarding the company's earnings before interest, taxes, depreciation, and amortization (EBITDA) guidance for the second to fourth quarters. Raymond James highlighted that the lower end of this guidance suggests about 16% growth compared to the previous year, excluding certain adjustments. This follows a quarter where the company experienced a 12% decline in normalized EBITDA. The firm believes that the market may remain skeptical about this optimistic outlook without additional supporting information.
Recent Earnings Performance#
Despite the downgrade, Universal Health Services recently reported first-quarter earnings that exceeded expectations. The company posted earnings per share of $5.62, surpassing analyst predictions of $5.41. Additionally, its revenue reached $4.49 billion, exceeding the forecast of $4.39 billion. However, analysts have noted ongoing pressures from trends in health insurance exchanges, which could impact future performance.
Analysts Adjust Price Targets#
In light of these developments, Mizuho has adjusted its price target for Universal Health Services from $267 to $230, citing seasonal challenges that may affect future EBITDA growth. Similarly, TD Cowen has lowered its price target from $245 to $230 while maintaining a 'Buy' rating, following the strong first-quarter results. TD Cowen noted that the company's adjusted EBITDA was 3% above consensus estimates, reflecting a blend of positive earnings and cautious outlooks from analysts.